XWELL PE Ratio 2010-2024 | XWEL

Current and historical p/e ratio for XWELL (XWEL) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. XWELL PE ratio as of May 21, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

XWELL PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-21 0.86 0.00
2024-12-31 1.51 $-3.62 0.00
2024-09-30 1.73 $-3.64 0.00
2024-06-30 1.80 $-5.03 0.00
2024-03-31 1.69 $-5.95 0.00
2023-12-31 1.74 $-6.75 0.00
2023-09-30 2.25 $-8.18 0.00
2023-06-30 4.00 $-7.40 0.00
2023-03-31 7.20 $-7.60 0.00
2022-12-31 7.20 $-7.00 0.00
2022-09-30 15.40 $-3.40 0.00
2022-06-30 13.80 $-0.80 0.00
2022-03-31 22.60 $0.00 0.00
2021-12-31 40.40 $0.60 67.33
2021-09-30 29.40 0 0.00
2021-06-30 30.80 $-3.00 0.00
2021-03-31 36.80 $-32.40 0.00
2020-12-31 23.80 $-67.00 0.00
2020-09-30 39.40 $-67.00 0.00
2020-06-30 83.80 $-165.81 0.00
2020-03-31 11.40 $-328.83 0.00
2019-12-31 40.20 $-390.64 0.00
2019-09-30 86.40 $-390.64 0.00
2019-06-30 116.40 $-421.84 0.00
2019-03-31 144.00 $-384.64 0.00
2018-12-31 192.00 $-1,368.14 0.00
2018-09-30 180.00 $-1,368.14 0.00
2018-06-30 348.00 $-1,476.15 0.00
2018-03-31 864.00 $-1,752.18 0.00
2017-12-31 1644.00 $-1,080.11 0.00
2017-09-30 1668.00 $-1,368.14 0.00
2017-06-30 1980.00 $-1,536.15 0.00
2017-03-31 2604.00 $-1,968.20 0.00
2016-12-31 2556.00 $-1,896.19 0.00
2016-09-30 3228.00 $-1,608.16 0.00
2016-06-30 2268.00 $-2,640.26 0.00
2016-03-31 1968.00 $-2,856.29 0.00
2015-12-31 2964.00 $-3,360.34 0.00
2015-09-30 6720.00 $-13,201.32 0.00
2015-06-30 6720.00 $-13,681.37 0.00
2015-03-31 7800.00 $-13,921.39 0.00
2014-12-31 6600.00 $-14,641.46 0.00
2014-09-30 11400.00 $-4,800.48 0.00
2014-06-30 41040.00 $-4,440.44 0.00
2014-03-31 41640.00 $-4,680.47 0.00
2013-12-31 35520.00 $-4,920.49 0.00
2013-09-30 34440.00 $-7,440.74 0.00
2013-06-30 38040.00 $-8,040.80 0.00
2013-03-31 38040.00 $-10,801.08 0.00
2012-12-31 34440.00 $-14,521.45 0.00
2012-09-30 34800.00 $-12,001.20 0.00
2012-06-30 46320.00 $-13,681.37 0.00
2012-03-31 19800.00 $-12,481.25 0.00
2011-12-31 11880.00 $-9,240.92 0.00
2011-09-30 17040.00 $-9,240.92 0.00
2011-06-30 14640.00 $-11,401.14 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.005B $0.034B
XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.538B 26.55
Elevance Health (ELV) United States $93.196B 12.03
CVS Health (CVS) United States $80.632B 10.02
Cencora (COR) United States $56.777B 19.75
DiDi Global (DIDIY) China $22.309B 33.86
Natera (NTRA) United States $21.101B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.924B 13.68
EUROFINS SCIENT (ERFSF) Luxembourg $12.447B 0.00
CochLear (CHEOY) Australia $11.597B 0.00
Revvity (RVTY) United States $11.030B 18.98
ICON (ICLR) Ireland $10.666B 9.92
Viatris (VTRS) United States $10.422B 3.58
Doximity (DOCS) United States $9.895B 46.09
Avantor (AVTR) United States $9.179B 13.34
Medpace Holdings (MEDP) United States $8.813B 23.41
HealthEquity (HQY) United States $8.752B 43.06
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
Charles River Laboratories (CRL) United States $7.050B 13.81
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.153B 24.48
BrightSpring Health Services (BTSG) United States $4.151B 38.42
Sotera Health (SHC) United States $3.639B 20.68
Alignment Healthcare (ALHC) United States $3.102B 0.00
Surgery Partners (SGRY) United States $2.973B 38.67
Concentras Parent (CON) United States $2.889B 16.70
Organon (OGN) United States $2.277B 2.42
Ardent Health Partners (ARDT) United States $2.164B 9.23
GeneDx Holdings (WGS) United States $2.058B 79.24
Premier (PINC) United States $1.902B 14.44
Progyny (PGNY) United States $1.875B 41.26
PACS (PACS) United States $1.606B 0.00
GoodRx Holdings (GDRX) United States $1.418B 28.36
Pediatrix Medical (MD) United States $1.302B 9.91
Teladoc Health (TDOC) United States $1.288B 0.00
Establishment Labs Holdings (ESTA) $1.089B 0.00
Agilon Health (AGL) United States $1.027B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.988B 15.43
Nutex Health (NUTX) United States $0.986B 14.90
AMN Healthcare Services Inc (AMN) United States $0.878B 8.22
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.718B 4.84
InnovAge Holding (INNV) United States $0.572B 0.00
Enhabit (EHAB) United States $0.537B 44.21
Auna S.A (AUNA) Luxembourg $0.518B 11.67
LifeMD (LFMD) United States $0.484B 0.00
Sonida Senior Living (SNDA) United States $0.484B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.429B 0.00
SBC Medicals (SBC) United States $0.368B 0.00
Beauty Health (SKIN) United States $0.212B 0.00
Oncology Institute (TOI) United States $0.210B 0.00
Performant Healthcare (PHLT) United States $0.210B 0.00
DocGo (DCGO) United States $0.142B 23.17
KindlyMD (KDLY) United States $0.092B 0.00
So-Young (SY) China $0.087B 0.00
OncoCyte (OCX) United States $0.084B 0.00
Sera Prognostics (SERA) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.067B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.040B 0.00
Basel Medical Group (BMGL) Singapore $0.037B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
ModivCare (MODV) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00